sodium-ethylxanthate and Leprosy

sodium-ethylxanthate has been researched along with Leprosy* in 5 studies

Reviews

1 review(s) available for sodium-ethylxanthate and Leprosy

ArticleYear
A woman with leprosy is in double jeopardy.
    Leprosy review, 2000, Volume: 71, Issue:2

    The double jeopardy associated with female leprosy patients is the central theme underpinning this essay. It constitutes a combination of biological factors unique to women and culturally defined bias, resulting in more stigmatization and isolation for women. Having examined the female immunological response and biological roles, the essay continues by focusing on the gender-culture perspective of leprosy. It draws upon an historical analysis of the experiences of Indian and African women to illustrate the ways in which gender roles impact upon health education and the utilization of health care services. Concluding comments suggest strategies that might improve female leprosy patient status, and views towards future research.

    Topics: Africa; Female; Humans; India; Leprosy; Pregnancy; Pregnancy Complications, Infectious; Sex; Social Isolation; Stereotyping; Women's Health

2000

Other Studies

4 other study(ies) available for sodium-ethylxanthate and Leprosy

ArticleYear
Sex differences in the absorption of dapsone after intramuscular injection.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1983, Volume: 51, Issue:3

    A trial was performed with a long-acting dapsone (DDS) injection, consisting of an aqueous suspension of dapsone crystals, in doses of 900 mg and 1200 mg. Forty-one Ethiopian leprosy patients, 13 women and 28 men, participated in the study. There appeared to be a large discrepancy in the serum concentration curves of dapsone between men and women. Following injection of 900 mg dapsone in men, a peak of 2.28 +/- 1.06 micrograms/ml (mean +/- S.D.) was observed in the first week. After two weeks the serum concentrations had fallen to 0.42 +/- 0.29 micrograms/ml, and after four weeks they fell to 0.11 +/- 0.09 micrograms/ml. Following injection in women, the curves were smooth with a peak in the first week of only 1.04 +/- 0.40 micrograms/ml, while the serum concentrations after four weeks were still 0.42 +/- 0.23 micrograms/ml. The differences between the mean curves of men and women were statistically significant (p less than 0.001). The 1200 mg dapsone injections were only given to men. The explanation of the sex difference in intramuscular absorption can probably be found in the differences in the thickness of gluteal fat in men and women. In these Ethiopian leprosy patients, the non-protein-bound fraction of dapsone comprised 17 +/- 4%. In saliva, 19.5 +/- 7.0% of the dapsone level in serum was found. Methemoglobin levels were raised but did not reach levels of clinical importance. No other significant side effects were observed.

    Topics: Absorption; Adolescent; Adult; Dapsone; Female; Humans; Injections, Intramuscular; Leprosy; Male; Middle Aged; Sex

1983
Ainhum in a female child involving a great toe.
    Dermatologica, 1967, Volume: 134, Issue:3

    Topics: Ainhum; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Female; Hallux; Humans; Leprosy; Sex; Spinal Cord Diseases; Syphilis

1967
Association between lepromatous leprosy and Australia antigen.
    Lancet (London, England), 1967, Jul-22, Volume: 2, Issue:7508

    Topics: Adolescent; Adult; Aged; Aging; Antigens; Child; Child, Preschool; Computers; Factor Analysis, Statistical; Female; Hepatitis; Humans; Immunodiffusion; Infant; Leprosy; Leukemia; Male; Middle Aged; Philippines; Sex

1967
Association between sex and type in leprosy: a variation on the theme.
    The Indian journal of medical research, 1963, Volume: 51

    Topics: Humans; Leprosy; Sex

1963